FIFTH THIRD BANCORP - SANGAMO THERAPEUTICS INC ownership

SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 211 filers reported holding SANGAMO THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.81 and the average weighting 0.1%.

Quarter-by-quarter ownership
FIFTH THIRD BANCORP ownership history of SANGAMO THERAPEUTICS INC
ValueSharesWeighting
Q2 2021$12,000
+1100.0%
1,000
+900.0%
0.00%
Q1 2021$1,000
-50.0%
1000.0%0.00%
Q4 2020$2,000
+100.0%
1000.0%0.00%
Q3 2020$1,0000.0%1000.0%0.00%
Q2 2020$1,0000.0%1000.0%0.00%
Q1 2020$1,000
-50.0%
100
-75.0%
0.00%
Q1 2017$2,000
+100.0%
4000.0%0.00%
Q4 2016$1,000
-50.0%
4000.0%0.00%
Q3 2016$2,0000.0%4000.0%0.00%
Q2 2016$2,000
-33.3%
400
-11.1%
0.00%
Q1 2016$3,000
-25.0%
450
+12.5%
0.00%
Q4 2015$4,000
+100.0%
4000.0%0.00%
Q3 2015$2,000
-50.0%
4000.0%0.00%
Q2 2015$4,000
-33.3%
4000.0%0.00%
Q1 2015$6,0000.0%4000.0%0.00%
Q4 2014$6,000
+50.0%
4000.0%0.00%
Q3 2014$4,000
-33.3%
4000.0%0.00%
Q2 2014$6,000
-14.3%
4000.0%0.00%
Q1 2014$7,0004000.00%
Other shareholders
SANGAMO THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
RA Capital Management 6,000,000$66,540,0006.69%
FIC CAPITAL INC 787,529$8,734,0003.47%
RA Capital Management 1,220,209$13,532,0001.36%
PRINCETON CAPITAL MANAGEMENT INC 114,120$1,266,0000.67%
Perceptive Advisors 800,000$8,872,0000.53%
Cormorant Asset Management, LP 361,000$4,003,0000.53%
Highlander Capital Management, LLC 43,500$482,0000.43%
APEX CAPITAL, LLC 439,900$4,878,0000.42%
WASATCH ADVISORS LP 3,091,386$34,283,0000.37%
Baker Brothers Advisors 3,230,932$35,831,0000.31%
View complete list of SANGAMO THERAPEUTICS INC shareholders